Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P-40<br />
ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />
Molybdenum Carbonyl Complexes as CO Releasing Molecules<br />
Lukas Kromer a and Carlos Romão* a,b<br />
a ITQB-UNL, Av. da República, Estação Agronómica Nacional, 2780-157 Oeiras, Portugal.<br />
b ALFAMA Lda., Taguspark, Núcleo Central 267, 2740-122 Porto Salvo, Portugal.<br />
E-mail: kromer@itqb.unl.pt<br />
Carbon Monoxide (CO) is an essential signalling molecule produced in the body. Endogenous<br />
overproduction <strong>of</strong> CO in pathological situations strongly suggests medicinal applications for CO.<br />
Rather than using CO gas; drug research is focused on the development <strong>of</strong> CO-releasing Molecules<br />
(CO-RMs). 1 Although there are a large number <strong>of</strong> CO-RMs known, few if any fulfil the essential<br />
criteria for use as drugs, such as solubility in aqueous solutions <strong>of</strong> physiological pH, stability during<br />
storage and controlled release <strong>of</strong> CO in vivo, and efficacy at non-toxic doses. Furthermore, targeting <strong>of</strong><br />
specific tissue is desirable. To obtain water-soluble organometallic complexes, they either have to be<br />
charged or contain ligands that can be ionised in aqueous solutions through protonation or<br />
deprotonation.<br />
Charged complexes were synthesised with two types <strong>of</strong> ligands: 1,3-diketone and 2-hydroxyketone<br />
ligands. Both types <strong>of</strong> ligand can be deprotonated and form anionic complexes with the general<br />
structure (Et4N)[Mo(O-O)(CO)4]. 2 A second series <strong>of</strong> neutral complexes bearing functional groups<br />
were synthesised with several mono- and bidentate amine ligands in a conventional microwave. 3<br />
OC<br />
CO<br />
Mo<br />
O<br />
OC<br />
CO<br />
O<br />
R<br />
R<br />
0, 1<br />
-<br />
OC<br />
OC<br />
Mo<br />
CO<br />
CO<br />
R 2<br />
N<br />
N<br />
R 2<br />
OC<br />
CO<br />
Mo<br />
NHR<br />
OC<br />
CO<br />
NHR<br />
98<br />
4.00<br />
3.50<br />
3.00<br />
2.50<br />
O<br />
.<br />
C 2.00<br />
e<br />
q<br />
1.50<br />
1.00<br />
0.50<br />
0.00<br />
CO‐Hb formation in blood<br />
0 20 40 60 80<br />
time [min]<br />
The synthesised complexes were fully characterised and investigated in terms <strong>of</strong> solubility,<br />
stability in aqueous solution and the CO release rate was determined both in vitro by GC-TCD as in ex<br />
vivo assays in sheep blood with an Oxymeter. The direct measurement <strong>of</strong> CO-Hb levels in sheep blood<br />
gives you an immediate answer about CO release under biological conditions. The water soluble,<br />
neutral amine complexes exhibited a ligand-dependant CO release rate decreasing from primary,<br />
secondary to tertiary amine ligands with half life times between 15 and 60 minutes. In contrary, the<br />
results from the non water soluble amine and the less stable anionic complexes showed the limitation<br />
<strong>of</strong> the setup, in which the solubility and stability under physiological conditions is crucial. In<br />
conclusion, complexes with tuneable CO release rates are accessible and led to further improvements<br />
in terms <strong>of</strong> stability and solubility <strong>of</strong> CO-RM’s.<br />
References<br />
1. R. Motterlini, B. E. Mann, R. Foresti, Expert Opin. Invest. Drugs 2005, 14, 1305-1318. (b) S. W.<br />
Ryter, L. E. Otterbein, Bioessays 2004, 26, 270-280. (c) R. Motterlini, J. E. Clark, R. Foresti, P.<br />
Sarathchandra, B. E. Mann and C. J. Green, Circ. Res. 2002, 90, E17-E24.<br />
2. G. Doyle, J. Organomet. Chem 1973, 61, 235-245.<br />
3. M. Ardon, G. Hogarth, D.T.W. Oscr<strong>of</strong>t, J. Organomet. Chem. 2004, 689, 2429-2435.<br />
a)<br />
b)<br />
c)